This inventor holds 5 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: University of Illinois, The George Washington University, Northwestern University. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 2,430 
3 out of 283 
1 out of 2,217 
Years Active: 2019-2026
Title: Innovator Spotlight: Sida Shen - A Pioneer in Pharmaceutical Patents
Introduction
Sida Shen is an accomplished inventor based in Chicago, Illinois, who has made significant contributions to the field of pharmaceuticals with four patents to her name. Her innovative research focuses on developing compounds that target critical biological pathways, offering potential treatments for various diseases, including cancer and neurological disorders.
Latest Patents
Sida Shen's latest patents showcase her expertise in creating novel compounds. One such patent details "Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors." This invention comprises compounds represented by a specific formula, including pharmaceutically acceptable salts and prodrugs. These compounds aim to treat diseases by inhibiting histone deacetylase, particularly beneficial for cancer treatment.
Another notable patent is titled "3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases." This invention features cyclopentene compounds designed to inhibit aminotransferases, such as gamma-aminobutyric acid (GABA) aminotransferase and ornithine aminotransferase. These compounds may be utilized in pharmaceutical compositions to address disorders like epilepsy, addiction, hepatocellular carcinoma, and non-small cell lung cancer.
Career Highlights
Sida has garnered extensive experience working with renowned institutions, including the University of Illinois and The George Washington University. Her research work is highly regarded in the pharmaceutical community, contributing to advancements in drug development and therapy.
Collaborations
Throughout her career, Sida has collaborated with various experts in the field, including her coworker Alejandro V. Villagra. These collaborations have further enriched her research, fostering innovations that address pressing health challenges.
Conclusion
Sida Shen's contributions to the realm of pharmaceuticals through her inventive patents reflect her commitment to scientific advancement. With her focus on developing treatments for critical health issues, she continues to influence the landscape of pharmaceutical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile